Edgewise Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC EWTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

98,063

Value ($000)

2,433

Weight

0.0%

2023 Q4 - 2025 Q4 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,433	0.0%	98,063	12/31/2025
2025 Q3	11/14/2025	2,256	0.0%	139,112	9/30/2025
2025 Q2	8/14/2025	2,512	0.0%	191,606	6/30/2025
2025 Q1	5/19/2025	6,003	0.0%	272,857	3/31/2025
2024 Q4	2/14/2025	7,453	0.0%	279,125	12/31/2024
2024 Q3	11/14/2024	2,250	0.0%	84,294	9/30/2024
2024 Q2	8/14/2024	1,438	0.0%	79,868	6/30/2024
2024 Q1	5/15/2024	591	0.0%	32,413	3/31/2024
2023 Q4	2/14/2024	258	0.0%	23,613	12/31/2023